Agilon Health, Inc.

NYSE:AGL

Medical - Care Facilities

Healthcare
$90.53 +2.16%

+$2.26 today

Market cap
$1.52B
Beta
3.04
P/E (TTM)
-4.8
EPS (TTM)
-$22.50
52W Low $7.48High $118.25

Volume 0.79M

Average 0.41M

AGL Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Agilon Health, Inc.NYSE: AGL

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin widens to 4.1%

Gross margin was 4.1% in Q1 FY2026, up 0.8 pp from a year earlier. On a trailing-twelve-month basis it was -2.7%, down 2.4 pp year over year. Over 3 fiscal years it narrowed by 7.8 pp.

Context

  • Gross margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
4.1%+10.3 pp QoQ
Last fiscal yearDec 2025
-3.2%-3.3 pp YoY
LTMMar 2026
-2.7%-2.4 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.8 pp——
1 year-3.3 pp——
3 years-7.8 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
-3.2%
Year-over-year change
-3.3pp

Gross Margin vs competitors

How AGL compares with its peers on the latest reported figures

  • AGL's LTM Mar 2026 gross margin of -2.7% is the 5th highest of the 6 companies compared; the peer median is 67.2%.
  • Its year-over-year change of -2.4 pp is the 4th highest of 6, against a peer median of -0.8 pp.
  • Over three fiscal years its change of -7.8 pp compares with a peer median of -13.3 pp.
AGL Competitors Peer median
Gross Margin for AGL and competitors
Company Period LTM level YoY 3-year change
DHDefinitive Healthcare Corp.LTM Mar 202672.5% -4.4 pp-5.0 pp
SOPHSOPHiA GENETICS S.A.LTM Mar 202667.3% -0.8 pp-3.8 pp
MCTACharming Medical Limited Class A Ordinary SharesFY202467.2% +2.1 pp—
SLPSimulations Plus, Inc.LTM Feb 202662.0% +6.7 pp-21.5 pp
AGLAgilon Health, Inc.LTM Mar 2026-2.7% -2.4 pp-7.8 pp
NAKANakamoto Inc.LTM Mar 2026-376.0% -309.7 pp-604.8 pp
ANNXAnnexon, Inc.FY2025— ——
LRMRLarimar Therapeutics, Inc.FY2025— ——
DBVTDBV Technologies S.A.FY2025— ——
ENGNenGene Holdings Inc.FY2025— ——
Peer median (excluding AGL) 67.2%-0.8 pp-13.3 pp

Competitors are the stored peer set for AGL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.52B2.39B4.32B6.06B5.93B
Cost of Revenue1.46B2.28B4.25B6.06B6.12B
Gross Profit65.74M111.36M69.67M4.84M(188.61M)
Gross Margin4.3%4.7%1.6%0.1%-3.2%
Research & Development00000
Selling, General & Admin427.5M207.79M285.76M268.91M238.54M
Operating Expenses437.99M216.74M301.8M296.97M232.46M
Depreciation & Amortization14.67M13.77M20.16M24.46M28.59M
EBITDA(362.16M)(72.41M)(167.64M)(218.19M)(368.86M)
EBITDA Margin-23.8%-3.0%-3.9%-3.6%-6.2%
Operating Income(372.24M)(105.38M)(232.13M)(292.13M)(421.08M)
Operating Margin-24.5%-4.4%-5.4%-4.8%-7.1%
Interest Income00000
Interest Expense6.15M4.48M6.66M6.18M6.64M
Other Income / Expenses(10.73M)14.71M37.67M43.3M16.98M
Income Before Tax(382.98M)(90.67M)(194.46M)(248.83M)(404.1M)
Pre-Tax Margin-25.2%-3.8%-4.5%-4.1%-6.8%
Income Tax Expense886K1.64M791K1.45M1.25M
Net Income(406.49M)(106.55M)(262.6M)(260.15M)(405.35M)
Net Margin-26.7%-4.5%-6.1%-4.3%-6.8%
EPS (Basic)(27.25)(6.50)(16.00)(15.75)(24.50)
EPS (Diluted)(27.25)(6.50)(16.00)(15.75)(24.50)
Weighted Avg Shares14.92M16.33M16.36M16.44M16.56M
Weighted Avg Shares (Diluted)14.92M16.33M16.36M16.44M16.56M

Agilon Health, Inc.

NYSE:AGL

Intrinsic Alpha fair value

Locked

Current Price

$90.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.